
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1089283-49-7 |
| Catalog No. | 2A-1170283 |
| Chinese Name | N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯 |
| Synonyms | gsk1904529a |
| Molecular Formula | C44H47F2N9O5S |
| Molecular Weight | 851.963 |
| Density | 1.4±0.1 g/cm3 |
| Appearance | powder |
| Storage Condition | -20℃ |
| Application | GSK1904529A is a selective inhibitor of IGF-1R and IR, with IC50 of 27 nM and 25 nM respectively. Its inhibitory effect on Akt1/2, Aurora A/B, B-Raf, CDK2, and EGFR is relatively weak. |
| PubChem ID | 56449061 |
| SMILES | CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1 |
| InChI | InChI=1S/C44H47F2N9O5S/c1-5-28-26-35(38(60-3)27-36(28)53-19-15-30(16-20-53)52-21-23-54(24-22-52)61(4,57)58)49-44-47-17-14-34(48-44)42-40(50-39-11-6-7-18-55(39)42)29-12-13-37(59-2)31(25-29)43(56)51-41-32(45)9-8-10-33(41)46/h6-14,17-18,25-27,30H,5,15-16,19-24H2,1-4H3,(H,51,56)(H,47,48,49) |
| InChI Key | MOSKATHMXWSZTQ-UHFFFAOYSA-N |
| Transport Info | Product name: GSK1904529A |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| NLG919 | 1402836-58-1 | 2A-1170276 |
| Ro 3306 | 872573-93-8 | 2A-1170277 |
| VRT-1353385 | 1616113-45-1 | 2A-1170278 |
| BMS 777607 | 1196681-44-3 | 2A-1170281 |
| Telatinib | 332012-40-5 | 2A-1170282 |
| 2,5-DICHLOROPHENETHYLAMINE | 56133-86-9 | 2A-1170284 |
| VX-702 | 479543-46-9 | 2A-1170284 |
| PF-01367338 | 459868-92-9 | 2A-1170285 |
| A-674563 | 552325-73-2 | 2A-1170287 |
| 5-(6-Quinoxalinylmethylene)-2,4-thiazolidinedione | 648450-29-7 | 2A-1170288 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA